Braunwald E. Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–9. https://doi.org/10.1056/NEJM199711063371906.
Article PubMed CAS Google Scholar
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322. https://doi.org/10.1161/CIR.0000000000000152.
Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–7. https://doi.org/10.1016/j.amjcard.2013.05.063.
McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS, Cardiovascular Research Network PRESERVE Study. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013;2:e005694. https://doi.org/10.1161/JAHA.112.005694.
Article PubMed PubMed Central Google Scholar
Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials: Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998;32:695–703.
Article PubMed CAS Google Scholar
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–5. https://doi.org/10.1161/01.CIR.0000072767.89944.6E.
Kotecha D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, Voors AA, Rienstra M. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol. 2016;68(20):2217–28. https://doi.org/10.1016/j.jacc.2016.08.048.
Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail. 2014;7(1):123–30. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000568.
Article PubMed CAS Google Scholar
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–33. https://doi.org/10.1056/NEJMoa021328.
Article PubMed CAS Google Scholar
Rillig A, Magnussen C, Ozga AK, et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation. 2021;144:845–58.
Article PubMed PubMed Central CAS Google Scholar
Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D, CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417–27. https://doi.org/10.1056/NEJMoa1707855.
Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial. Circulation. 2016;133(17):1637–44. https://doi.org/10.1161/CIRCULATIONAHA.115.019406.
Article PubMed CAS Google Scholar
TriNetX. Penn State Clinical and Translational Science Institute. Available at: https://ctsi.psu.edu/research-support/trinetx/. Accessed 10/4/2023.
Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G, EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–16. https://doi.org/10.1056/NEJMoa2019422.
Kim D, Yang PS, You SC, et al. Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study. BMJ. 2021;373:n991.
Article PubMed PubMed Central Google Scholar
Dickow J, Kirchhof P, Van Houten HK, et al. Generalizability of the EAST-AFNET 4 Trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation. J Am Heart Assoc. 2022;11:1–11.
Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156. https://doi.org/10.1161/CIR.0000000000001193. Epub 2023 Nov 30. Erratum in: Circulation. 2024 Jan 2;149(1):e167. PMID: 38033089.
Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667–77.
Article PubMed CAS Google Scholar
Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol. 2006;48:2340–7. https://doi.org/10.1016/j.jacc.2006.08.037.
Article PubMed CAS Google Scholar
Rattka M, Pott A, Kühberger A, Weinmann K, Scharnbeck D, Stephan T, et al. Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients. Europace. 2020;22:1328–36.
Article PubMed PubMed Central Google Scholar
Saksena S, Slee A, Natale A, Lakkireddy DR, Shah D, Di Biase L, et al. Atrial fibrillation can adversely impact heart failure with preserved ejection fraction by its association with heart failure progression and mortality: a post-hoc propensity score-matched analysis of the TOPCAT Americas trial. Europace. 2023;25:euad095.
Article PubMed PubMed Central Google Scholar
Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D’Avila A, Dobrev D, et al. Document Reviewers: EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18:1455–90. https://doi.org/10.1093/europace/euw161.
Article PubMed PubMed Central Google Scholar
Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498–506. https://doi.org/10.1001/jama.2014.3.
Article PubMed CAS Google Scholar
Risom SS, Zwisler AD, Thygesen LC, Svendsen JH, Berg SK. High readmission rates and mental distress 1 yr after ablation for atrial fibrillation or atrial flutter: a nationwide survey. J Cardiopulm Rehabil Prev. 2019;39(1):33–8. https://doi.org/10.1097/HCR.0000000000000395.
Tseng AS, Patel HP, Kumar A, Jani C, Patel K, Jaswaney R, Thakkar S, Kowlgi NG, Dani SS, Arora S, Mulpuru SK, Madhavan M, Killu AM, Cha YM, DeSimone CV, Deshmukh A. One-year outcomes of catheter ablation for atrial fibrillation in young patients. BMC Cardiovasc Disord. 2023;23(1):83. https://doi.org/10.1186/s12872-022-03017-6.
Article PubMed PubMed Central Google Scholar
Noseworthy PA, Kapa S, Haas LR, Van Houten H, Deshmuk AJ, Mulpuru SK, McLeod CJ, Asirvatham SJ, Friedman PA, Shah ND, Packer DL. Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009–2013. Am Heart J. 2015;170(3):483–9. https://doi.org/10.1016/j.ahj.2015.05.018.
Arora S, Jaswaney R, Jani C, Zuzek Z, Thakkar S, Patel HP, Patel M, Patel N, Tripathi B, Lahewala S, Arora N, Josephson R, Osman MN, Hoit BD, Kowlgi G, Mulpuru SK, DeSimone CV, Viles-Gonzalez J, Deshmukh A. Catheter ablation for atrial fibrillation in patients with concurrent heart failure. Am J Cardiol. 2020;15(137):45–54. https://doi.org/10.1016/j.amjcard.2020.09.035.
Xie Z, Qi B, Wang Z, Li F, Chen C, Li C, Yuan S, Yao S, Zhou J, Ge J. Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction. Europace. 2023;26(1):euad363. https://doi.org/10.1093/europace/euad363.
Comments (0)